101 related articles for article (PubMed ID: 22696877)
1. Evaluation of antibodies against glycoprotein D (gD) and glycoprotein G (gG) in HSV-1 infected individuals' serum samples.
Meshkat Z; Roostaee MH; Soleimanjahi M; Zandi K
Eur Rev Med Pharmacol Sci; 2012 Apr; 16(4):499-502. PubMed ID: 22696877
[TBL] [Abstract][Full Text] [Related]
2. [ELISA study on application of recombinant glycoprotein D of herpes simplex virus-1 in diagnosis of herpes simplex virus-1 infection with ELISA].
Wang ZY; Wang ZY; Wen HL; Tao ZX
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Jun; 19(2):159-61. PubMed ID: 16027786
[TBL] [Abstract][Full Text] [Related]
3. The glycoproteins C and G are equivalent target antigens for the determination of herpes simplex virus type 1-specific antibodies.
Scheper T; Saschenbrecker S; Steinhagen K; Sauerbrei A; Suer W; Meyer W; Schlumberger W; Wandinger KP
J Virol Methods; 2010 Jun; 166(1-2):42-7. PubMed ID: 20171247
[TBL] [Abstract][Full Text] [Related]
4. Development of an HSV-1 neutralization test with a glycoprotein D specific antibody for measurement of neutralizing antibody titer in human sera.
Luo Y; Xiong D; Li HH; Qiu SP; Lin CL; Chen Q; Huang CH; Yuan Q; Zhang J; Xia NS
Virol J; 2016 Mar; 13():44. PubMed ID: 26987753
[TBL] [Abstract][Full Text] [Related]
5. Comparison of immunoassays for differentiation of herpes simplex virus type 1 and 2 antibodies.
Qutub MO; Klapper PE; Vallely PJ; Cleator GM; Mandall D
Saudi Med J; 2006 Jun; 27(6):788-93. PubMed ID: 16758036
[TBL] [Abstract][Full Text] [Related]
6. Coexpression of interleukin-2 enhances the immunization effect of a DNA vaccine expressing herpes simplex 1 glycoprotein D.
Li WR; Niu B; Wang JW; Feng ZJ; Wang DX
Acta Virol; 2006; 50(4):251-6. PubMed ID: 17177610
[TBL] [Abstract][Full Text] [Related]
7. Protection against herpes simplex virus-induced eye disease after vaccination with seven individually expressed herpes simplex virus 1 glycoproteins.
Ghiasi H; Bahri S; Nesburn AB; Wechsler SL
Invest Ophthalmol Vis Sci; 1995 Jun; 36(7):1352-60. PubMed ID: 7775113
[TBL] [Abstract][Full Text] [Related]
8. Inaccuracy of certain commercial enzyme immunoassays in diagnosing genital infections with herpes simplex virus types 1 or 2.
Morrow RA; Friedrich D
Am J Clin Pathol; 2003 Dec; 120(6):839-44. PubMed ID: 14671972
[TBL] [Abstract][Full Text] [Related]
9. Identification of a herpes B virus-specific glycoprotein d immunodominant epitope recognized by natural and foreign hosts.
Perelygina L; Zurkuhlen H; Patrusheva I; Hilliard JK
J Infect Dis; 2002 Aug; 186(4):453-61. PubMed ID: 12195371
[TBL] [Abstract][Full Text] [Related]
10. Limits in reliability of glycoprotein G-based type-specific serologic assays for herpes simplex virus types 1 and 2.
Schmid DS; Brown DR; Nisenbaum R; Burke RL; Alexander D; Ashley R; Pellett PE; Reeves WC
J Clin Microbiol; 1999 Feb; 37(2):376-9. PubMed ID: 9889222
[TBL] [Abstract][Full Text] [Related]
11. Serological testing for herpes simplex virus (HSV)-1 and HSV-2 infection.
Wald A; Ashley-Morrow R
Clin Infect Dis; 2002 Oct; 35(Suppl 2):S173-82. PubMed ID: 12353203
[TBL] [Abstract][Full Text] [Related]
12. Characterization of B virus glycoprotein antibodies induced by DNA immunization.
Perelygina L; Patrusheva I; Zurkuhlen H; Hilliard JK
Arch Virol; 2002 Nov; 147(11):2057-73. PubMed ID: 12417944
[TBL] [Abstract][Full Text] [Related]
13. Expression and characterization of herpes simplex virus type 1 (HSV-1) glycoprotein G (gG) by recombinant vaccinia virus: neutralization of HSV-1 infectivity with anti-gG antibody.
Sullivan V; Smith GL
J Gen Virol; 1987 Oct; 68 ( Pt 10)():2587-98. PubMed ID: 2822841
[TBL] [Abstract][Full Text] [Related]
14. Acute retinal necrosis six years after herpes simplex encephalitis: an elusive immune deficit suggested by insufficient test sensitivity.
Preiser W; Doerr HW; Buxbaum S; Rabenau HF; Baatz H
J Med Virol; 2004 Jun; 73(2):250-5. PubMed ID: 15122800
[TBL] [Abstract][Full Text] [Related]
15. Use of a fragment of glycoprotein G-2 produced in the baculovirus expression system for detecting herpes simplex virus type 2-specific antibodies.
Ikoma M; Liljeqvist JA; Groen J; Glazenburg KL; The TH; Welling-Wester S
J Clin Microbiol; 2002 Jul; 40(7):2526-32. PubMed ID: 12089274
[TBL] [Abstract][Full Text] [Related]
16. Production of a fragment of glycoprotein G of herpes simplex virus type 2 and evaluation of its diagnostic potential.
Liu T; Liu JF; Yu H; Si GJ; Hu J; Li J
Singapore Med J; 2015 Jun; 56(6):346-52. PubMed ID: 25532518
[TBL] [Abstract][Full Text] [Related]
17. Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis.
Ritchie MH; Oakes JE; Lausch RN
Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2460-8. PubMed ID: 8392037
[TBL] [Abstract][Full Text] [Related]
18. Discrimination of antibody to herpes B virus from antibody to herpes simplex virus types 1 and 2 in human and macaque sera.
Fujima A; Ochiai Y; Saito A; Omori Y; Noda A; Kazuyama Y; Shoji H; Tanabayashi K; Ueda F; Yoshikawa Y; Hondo R
J Clin Microbiol; 2008 Jan; 46(1):56-61. PubMed ID: 17989200
[TBL] [Abstract][Full Text] [Related]
19. Herpes simplex virus type-2 specific glycoprotein G-2 immunomagnetically captured from HEp-2 infected tissue culture extracts.
Clavet CR; Margolin AB; Regan PM
J Virol Methods; 2004 Aug; 119(2):121-8. PubMed ID: 15158593
[TBL] [Abstract][Full Text] [Related]
20. Role of anti-glycoproteins D (anti-gD) and K (anti-gK) IgGs in pathology of herpes stromal keratitis in humans.
Mott KR; Osorio Y; Maguen E; Nesburn AB; Wittek AE; Cai S; Chattopadhyay S; Ghiasi H
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2185-93. PubMed ID: 17460278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
